Skip to content

Drug overdose deaths are down for the first time in 30 years. Is this the turning point of the overdose crisis?

Photo by Matthew Modoono/Northeastern University

Drug overdoses cause more deaths in the U.S. than gun violence, car accidents, or H.I.V. did when they reached their most lethal peaks. For almost three decades, the number of overdose deaths increased unabated. But, according to a recent government report, the U.S. experienced a slight decrease in overdose deaths last year, marking the first decline in drug mortality rates since 1990. 

Leo Beletsky, a Northeastern professor of law and health sciences and the director of the Health in Justice Action Lab, says this drop is certainly something to cautiously celebrate, despite being only a little more than a 2 percent decrease.  

Leo Beletsky is a Northeastern professor of law and health sciences and faculty director of the Health in Justice Action Lab. Photo by Matthew Modoono/Northeastern University

“The fact that we’re seeing a decrease is definitely good news because in past years, instead of seeing decreases, we’ve sometimes seen double digit increases,” Beletsky says.

However, there’s still a lot of work to be done in treating addiction. According to the provisional statistics laid out in the report, the Centers for Disease Control and Prevention estimated that overdose deaths were down from 70,237 in 2017 to 68,557 in 2018. But while that is definitely a decrease, those numbers are still incredibly high. 

“This is positive progress either way,” Beletsky says. “But the magnitude of this new trend is highly subject to error, which is always something to consider when we talk about the actual measurement of overdose deaths.” 

The estimated numbers from the CDC are subject to change since drug overdose deaths are often reported “pending investigation” without a cause of death, according to the organization. The final results will not be released for several months. 

Some reports state that the decrease in overdose deaths is the result of a decline in opioid painkillers, which have been less widely prescribed in recent years. But Beletsky says, “I’m dubious of those claims.”  

“No one knows if that’s true, and people who say that they know have a level of wishful thinking,” he says. 

The report showed a decrease in deaths related to opioid painkillers and an increase in deaths related to illicit opioids like heroin and fentanyl, suggesting that instead of preventing overdoses, a restriction in prescription painkillers may have led users to seek illicit, often riskier, opioids. 

“We’ve been seeing this trend since about 2008,” Beletsky says. “As efforts to restrict prescription opioids has succeeded, a lot of people have moved on to using street drugs, which has been a main driver of overdose.” 

In terms of treatment and prevention, Beletsky says there should be more of an emphasis on proven solutions like naloxone and methadone or buprenorphine. Naloxone is a medication that reverses the effects of opioid overdoses, and methadone and buprenorphine are medications that treat opioid addiction. 

In general though, Beletsky says that the approach to solving this overdose crisis needs to be more holistic. “We need to address the underlying problems. The truth is, people experience pain. We need to make sure they have adequate access to healthcare,” he says.  

So, are these numbers the start of a downward trend in overdose deaths? Beletsky hopes so, but he also warns that “sometimes victory on one front creates a blind spot on another front.” With death rates still exceeding 68,000, there’s still a long way to go. 

For media inquiries, please contact media@northeastern.edu.

Cookies on Northeastern sites

This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.

Like what you see? Sign up for our daily newsletter to get the latest stories right in your inbox.